KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Other Non-Current Assets (2016 - 2025)

Amgen (AMGN) has 17 years of Other Non-Current Assets data on record, last reported at $12.7 billion in Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 27.49% year-over-year to $12.7 billion; the TTM value through Dec 2025 reached $12.7 billion, up 27.49%, while the annual FY2025 figure was $12.7 billion, 27.49% up from the prior year.
  • Other Non-Current Assets reached $12.7 billion in Q4 2025 per AMGN's latest filing, down from $13.2 billion in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $13.2 billion in Q3 2025 and bottomed at $5.8 billion in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $8.4 billion, with a median of $7.7 billion recorded in 2023.
  • Peak YoY movement for Other Non-Current Assets: fell 9.58% in 2022, then skyrocketed 62.93% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $6.5 billion in 2021, then decreased by 9.58% to $5.9 billion in 2022, then surged by 62.93% to $9.6 billion in 2023, then increased by 3.32% to $9.9 billion in 2024, then increased by 27.49% to $12.7 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $12.7 billion in Q4 2025, $13.2 billion in Q3 2025, and $11.0 billion in Q2 2025.